References
- TorreLASiegelRLWardEMJemalAGlobal Cancer Incidence and Mortality Rates and Trends–An UpdateCancer Epidemiol Biomarkers Prev201625162726667886
- National Cancer InstituteCancer Trends Progress Report - 2009/2010 Update Available from: URL: http://progressreport.cancer.gov/Accessed 2015 March
- El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology20071322557257617570226
- GalunDBasaricDZuvelaMHepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsWorld J Hepatol20157202274229126380652
- NojiriSKusakabeAFujiwaraKClinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinomaCancer Manag Res2012442342923293537
- NojiriSKusakabeAShinkaiNFactors influencing distant recurrence of hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization therapy in patients with hepatitis CCancer Manag Res2011326727221847355
- FornerAReigMde LopeCRBruixJCurrent strategy for staging and treatment: the BCLC update and future prospectsSemin Liver Dis201030617420175034
- AbdallaEDenysAHasegawaKTreatment of large and advanced hepatocellular carcinomaAnn Surg Oncol200815497998518236115
- ChangYJChungKPChangYJChenLJLong-term survival of patients undergoing liver resection for very large hepatocellular carcinomasBr J Surg20161031513152027550624
- VitaleABurraPFrigoACItalian Liver Cancer (ITA.LI.CA) groupSurvival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre studyJ Hepatol20156261762425450706
- IshizawaTHasegawaKAokiTNeither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinomaGastroenterology20081341908191618549877
- HanKQHeXQMaMYInflammatory microenvironment and expression of chemokines in hepatocellular carcinomaWorld J Gastroenterol201521164864487425944999
- YuJRenXChenYDysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patientsPLoS One201382e5606923418512
- ShaoYYLinHLiYSHigh plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinomaJpn J ClinOncol20174710949953
- ZhuYLiJHYangJGaoXMJiaHLYangXInflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resectionMedicine (Baltimore)20179639e805628953624
- GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
- ZhangJZhangHYLiJThe elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysisOncotarget2017840688376884628978160
- LietoEGaliziaGAuricchioAPreoperative neutrophil to lymphocyte ratio and lymphocyte to monocyte ratio are prognostic factors in gastric cancers undergoing surgeryJ Gastrointest Surg201721111764177428752404
- YinYWangJWangXPrognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysisClinics (Sao Paulo)201570752453026222823
- YangJJHuZGShiWXDengTHeSQYuanSGPrognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisWorld J Gastroenterol20152192807281525759553
- LuSDWangYYPengNFPreoperative ratio of neutrophils to lymphocytes predicts postresection survival in selected patients with early or intermediate stage hepatocellular carcinomaMedicine (Baltimore)2016955e272226844516
- DanJZhangYPengZPostoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablationPloS One20138e5818423516447
- FanWZhangYWangYNeutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolizationPloS One201510e011931225742141
- LimayeARClarkVSoldevila-PicoCNeutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinomaHepatol Res20134375776423193965
- da FonsecaLGBarroso-SousaRBento AdaSPre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenibMed Oncol20143126425273866
- ManoYShirabeKYamashitaYPreoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysisAnn Surg201325830130523774313
- KinoshitaAOnodaHImaiNComparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinomaBr J Cancer201210798899322878374
- FuSJShenSLLiSQPrognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV associated hepatocellular carcinoma after radical hepatectomyMed Oncol20133072124026659
- LiaoWZhangJZhuQPreoperative neutrophil-to lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resectionTransl Oncol2014724825524704092
- SullivanKMGroeschlRTTuragaKKNeutrophil-to lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspectiveJ Surg Oncol2014109959724122764
- GomezDFaridSMalikHZPreoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinomaWorld J Surg2008321757176218340479
- van MeerSvan ErpecumKJSprengersDHepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the NetherlandsEur J Gastroenterol Hepatol201628335235926629867
- BeardREHantoDWGautamSMiksadRAA comparison of surgical outcomes for noncirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institutionSurgery2013154354555523777589
- European Association for Study of the Liver, European Organisation for Research and Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaEur J Cancer201248559964122424278
- MilicevicMBulajicPZuvelaMDervenisCBasarićDGalunDA radiofrequency-assisted minimal blood loss liver parenchyma dissection techniqueDig Surg200724430631317657157
- GalunDBulajicPZuvelaMBasaricDIlleTMilicevicMNIs there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing countryWorld J Surg20123671657166522395347
- PangYYThe Brisbane 2000 terminology of liver anatomy and resectionsHPB20002333339
- BronsonNEnestvedtKThomasEPreoperative neutrophil to lymphocyte ratio does not predict recurrence or prognosis after resection for hepatocellular carcinomaHPB201214456
- PollardJWTumour-educated macrophages promote tumour progression and metastasisNat Rev Cancer20044717814708027
- CoussensLMWerbZInflammation cancerNature200242086086712490959
- WuYZhaoQPengCSunLLiXFKuangDMNeutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loopJ Pathol201122543844721826665
- McDonaldBSpicerJGiannaisBFallavollitaLBrodtPFerriLESystemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanismsInt J Cancer20091251298130519431213
- KusumantoYHDamWAHospersGAMeijerCMulderNHPlatelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factorAngiogenesis2003628328715166496
- MullerIMunderMKropfPHänschGMPolymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?Trends Immunol20093052253019775938
- SchreiberRDOldLJSmythMJCancer immunoediting: integrating immunity’s roles in cancer suppression and promotionScience20113311565157021436444
- SvennevigJLLundeOCHolterJBjorgsvikDLymphoid infiltration and prognosis in colorectal carcinomaBr J Cancer1984493753776704315
- OkanoKMaebaTMoroguchiALymphocytic infiltration surrounding liver metastases from colorectal cancerJ Surg Oncol200382283312501166
- TretiakovaMSShabani-RadMTGuggisbergKHartJAndersRAGaoZHGenomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosisHistopathology20105668369320546333
- YoungALAdairRPrasadKRHepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomesJ Am Coll Surg201221417418322137823
- ZhengJCaiJLiHNeutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic reviewCell Physiol Biochem201744396798129179180
- WangQBlankSFielMIThe severity of liver fibrosis influences the prognostic value of inflammation-based scores in hepatitis B-associated hepatocellular carcinomaAnn Surg Oncol201522S1125S113226159441
- ParadisVZalinskiSChelbiEHepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysisHepatology20094985185919115377
- BrowningJDHortonJDMolecular mediators of hepatic steatosis and liver injuryJ Clin Invest200411414715215254578
- ReuterSGuptaSCChaturvediMMAggarwalBBOxidative stress, inflammation, and cancer: how are they linked?Free Radic Biol Med2010491603161620840865
- NajjarMAgrawalSEmondJCHalazunKJPretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinomaJ Hepatocell Carcinoma20185172829404284
- CoussensLMWerbZInflammation cancerNature200242086086712490959
- FenwickSWToogoodGJLodgeJPHullMAThe effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastasesGastroenterology200312571672912949718
- LesterhuisWJde VriesIJSchuurhuisDHVaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin testsAnn Oncol200617697498016600979
- XuXSWanYSongSDModel based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosisWorld J Gastroenterol20142031109441095225152598